Barry E. Greene
2020 - Alnylam Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $376,380 |
|---|---|
| Option Awards | $8,313,010 |
| Salary | $484,000 |
| Stock Awards | $457,596 |
| Other | $717,332 |
| Total | $10,348,318 |
Greene received $8.3M in option awards, accounting for 80% of the total pay in 2020.
Greene also received $376.4K in non-equity incentive plan, $484K in salary, $457.6K in stock awards and $717.3K in other compensation.
Rankings
In 2020, Barry E. Greene's compensation ranked 794th out of 13,090 executives tracked by ExecPay. In other words, Greene earned more than 93.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 794 out of 13,090 | 94th |
Division Manufacturing | 279 out of 5,620 | 95th |
Major group Chemicals And Allied Products | 89 out of 2,253 | 96th |
Industry group Drugs | 78 out of 1,953 | 96th |
Industry Pharmaceutical Preparations | 59 out of 1,458 | 96th |
Pay ratio
| Barry E. Greene's Pay | $10,348,318 |
|---|---|
| Median Employee's Pay | $233,341 |
| Pay Ratio | 44to 1 |
In 2020, the annual total compensation of Barry E. Greene was $10,348,318.
The annual total compensation of the median employee at Alnylam Pharmaceuticals was $233,341.
The ratio of Barry E. Greene's pay to the pay of median employee was therefore 44 to one.
Greene's colleagues
We found five more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2020.
2020
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2020
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2020
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2020
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
2020
Laurie Keating
Alnylam Pharmaceuticals